Monte Rosa Therapeutics CSO Sharon Townson Liquidates $139,849 in Shares Amid Pipeline Progress
Sharon Townson, Chief Scientific Officer at Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE), executed a series of stock sales totaling approximately $139,849 on July 6, 2026. The transaction involved the liquidation of 6,000 shares of common stock, which were sold following the exercise of fully vested stock options. This insider activity occurs agains…